Zentalis
Zentalis Pharmaceuticals is a clinical-stage company advancing azenosertib, a first-in-class WEE1 inhibitor, for ovarian cancer and other tumor types.
Backed by Decheng Capital LLC
Traction is an independent job board.
This listing is read from the company’s own careers page and links straight back to it. We never receive your application.